Sign inJoin waitlistJoin the waitlist

DM

Daniel Mendez-Allwood

Physician · Oregon Specialty Group

Credentials: · · ·

History

Oregon Specialty Group
2020–Present

Rheumatology
2005–2007
Internal Medicine
2002–2005
Medical School
1998–2002

Research

Ofatumumab, a second-generation anti-CD20 monoclonal antibody, for the treatment of lymphoproliferative and autoimmune disorders
Expert Opinion on Investigational Drugs · 2009 · Last of 3 authors · 52 citations

CM
Cannon Milani
1 paper · 1 as a fellow
Jorge Castillo
1 paper